Fimasartan Blood Pressure Lowering After Acute Stroke "FABULOUS"


Phase N/A Results N/A

Summary of Purpose

This study evaluates the effectiveness of fimasartan-based antihypertensive treatment and prognosis in post-acute phase of ischemic stroke or transient ischemic attack patients. All participants will receive fimasartan, and the investigators will follow them up for 6 months.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 July 2017.

28 Jul 2016 25 Jul 2017 30 May 2018 30 Dec 2019 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available